Beximco Pharma (BXP.L*): COVID-19 update | Open Orphan (ORPH.L): £3.5m contract with a US biotechnology company.
04 May 2020
SP Angel Healthcare Conditions
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
SP Angel Healthcare Conditions
- Published:
04 May 2020 -
Author:
Vadim Alexandre | Liam Gascoigne-Cohen -
Pages:
3
Beximco Pharma (BXP.L*): COVID-19 update | Open Orphan (ORPH.L): £3.5m contract with a US biotechnology company.